tradingkey.logo
搜尋

Revvity Inc

RVTY
添加自選
112.520USD
-1.020-0.90%
收盤 07-31 16:00美東報價延遲15分鐘
12.55B總市值
54.04本益比TTM

關於 Revvity Inc 公司

Revvity, Inc. is a provider of health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. The Company has specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards the life sciences market. The segment offers instruments, reagents, software, detection and imaging technologies, and others. The Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. The segment offers instruments, reagents, assay platforms and software to hospitals, medical labs, clinicians and medical research professionals to help improve the health of families.

Revvity Inc簡介

公司代碼RVTY
公司名稱Revvity Inc
上市日期Aug 12, 2101
CEOSingh (Prahlad R)
員工數量11000
證券類型Ordinary Share
年結日Aug 12
公司地址77 4Th Avenue
城市WALTHAM
上市交易所NASDAQ OMX NASDAQ Basic NYSE
國家United States of America
郵編02451
電話17816636900
網址https://www.revvity.com/
公司代碼RVTY
上市日期Aug 12, 2101
CEOSingh (Prahlad R)

Revvity Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Dr. Prahlad R. Singh, Ph.D.
Dr. Prahlad R. Singh, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
113.31K
+14.54%
Mr. Alexandros P. (Alexis) Michas
Mr. Alexandros P. (Alexis) Michas
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
63.77K
+4.21%
Mr. Joel S. Goldberg
Mr. Joel S. Goldberg
Senior Vice President - Administration, General Counsel, Secretary
Senior Vice President - Administration, General Counsel, Secretary
41.51K
+9.21%
Dr. Peter Barrett, Ph.D.
Dr. Peter Barrett, Ph.D.
Independent Director
Independent Director
28.29K
+8.06%
Ms. Miriame Victor
Ms. Miriame Victor
Chief Commercial Officer, Senior Vice President
Chief Commercial Officer, Senior Vice President
18.12K
+21.16%
Mr. Maxwell Krakowiak
Mr. Maxwell Krakowiak
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
16.41K
-38.94%
Ms. Pascale Witz
Ms. Pascale Witz
Independent Director
Independent Director
15.98K
+14.26%
Mr. Tajinder S. Vohra
Mr. Tajinder S. Vohra
Senior Vice President - Global Operations
Senior Vice President - Global Operations
13.96K
+25.23%
Mr. Michael A. Klobuchar
Mr. Michael A. Klobuchar
Independent Director
Independent Director
7.37K
+30.94%
Dr. Sophie V. Vandebroek, Ph.D.
Dr. Sophie V. Vandebroek, Ph.D.
Independent Director
Independent Director
7.37K
+30.94%
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. Prahlad R. Singh, Ph.D.
Dr. Prahlad R. Singh, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
113.31K
+14.54%
Mr. Alexandros P. (Alexis) Michas
Mr. Alexandros P. (Alexis) Michas
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
63.77K
+4.21%
Mr. Joel S. Goldberg
Mr. Joel S. Goldberg
Senior Vice President - Administration, General Counsel, Secretary
Senior Vice President - Administration, General Counsel, Secretary
41.51K
+9.21%
Dr. Peter Barrett, Ph.D.
Dr. Peter Barrett, Ph.D.
Independent Director
Independent Director
28.29K
+8.06%
Ms. Miriame Victor
Ms. Miriame Victor
Chief Commercial Officer, Senior Vice President
Chief Commercial Officer, Senior Vice President
18.12K
+21.16%
Mr. Maxwell Krakowiak
Mr. Maxwell Krakowiak
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
16.41K
-38.94%

常見問題

Revvity Inc的前五大股東是誰?

Revvity Inc的前五大股東如下:Dr. Prahlad R. Singh, Ph.D.

有多少機構持有Revvity Inc(RVTY)的股份?

截至2026Q1,共有1187家機構持有Revvity Inc的股份,合計持有的股份價值約為116.42M,占公司總股份的104.13% 。與2025Q4相比,機構持股有所增加,增幅為-12219072.00。
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有